The US Food and Drug Administration (FDA) has given its nod for the marketing of anti-malaria tablets, atovaquone and proguanil hydrochloride in the country
![Glenmark Receives FDA Approval for Anti-Malaria Tablets Glenmark Receives FDA Approval for Anti-Malaria Tablets](https://www.medindia.net/afp/images/Zambia-health-malaria-21613.jpg)
The approval comes after the company said that it had settled a lawsuit with GlaxoSmithKline in April 2010 which gives it the royalty license to market atovaquone/proguanil 250mg/100mg tablets, which are generic variants of GSK’s Malarone tablets.
“Glenmark believes that it is entitled to 180 days of exclusivity with respect to its atovaquone/proguanil 250mg/100mg tablets as the first generic to file an ANDA for the product”, Glenmark said in a statement.
Source-Medindia